T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials
Efficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immune responses by maintaining homeostasis. The role o...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/4/3/30 |
_version_ | 1811299482220888064 |
---|---|
author | Vedran Brezar Véronique Godot Liang Cheng Lishan Su Yves Lévy Nabila Seddiki |
author_facet | Vedran Brezar Véronique Godot Liang Cheng Lishan Su Yves Lévy Nabila Seddiki |
author_sort | Vedran Brezar |
collection | DOAJ |
description | Efficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immune responses by maintaining homeostasis. The role of Tregs in inflammatory conditions is ambiguous and their systematic monitoring in vaccination along with effector T-cells is not instinctive. Recent studies from the cancer field clearly showed that Tregs suppress vaccine-induced immune responses and correlate with poor clinical benefit. In HIV infection, Tregs are needed during acute infection to preserve tissue integrity from an overwhelmed activation, but are not beneficial in chronic infection as they suppress anti-HIV responses. Current assays used to evaluate vaccine-induced specific responses are limited as they do not take into account antigen-specific Tregs. However, new assays, such as the OX40 assay, which allow for the simultaneous detection of a full range of Th-responses including antigen-specific Tregs responses, can overcome these issues. In this review article we will revise the role of Tregs in vaccination and review the recent work performed in the field, including the available tools to monitor them, from novel assays to humanized mouse models. |
first_indexed | 2024-04-13T06:36:37Z |
format | Article |
id | doaj.art-86dcbd55882749c38f74986bb62090e8 |
institution | Directory Open Access Journal |
issn | 2076-393X |
language | English |
last_indexed | 2024-04-13T06:36:37Z |
publishDate | 2016-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Vaccines |
spelling | doaj.art-86dcbd55882749c38f74986bb62090e82022-12-22T02:57:54ZengMDPI AGVaccines2076-393X2016-09-01433010.3390/vaccines4030030vaccines4030030T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine TrialsVedran Brezar0Véronique Godot1Liang Cheng2Lishan Su3Yves Lévy4Nabila Seddiki5Institut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceDepartment of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USADepartment of Microbiology and Immunology, Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USAInstitut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceInstitut National de la Santé et de la Recherche Médicale (INSERM), U955, Equipe 16, Créteil 94000, FranceEfficient vaccines are characterized by the establishment of long-lived memory T cells, including T-helper (effectors and follicular) and T-regulatory cells (Tregs). While the former induces cytotoxic or antibody responses, the latter regulates immune responses by maintaining homeostasis. The role of Tregs in inflammatory conditions is ambiguous and their systematic monitoring in vaccination along with effector T-cells is not instinctive. Recent studies from the cancer field clearly showed that Tregs suppress vaccine-induced immune responses and correlate with poor clinical benefit. In HIV infection, Tregs are needed during acute infection to preserve tissue integrity from an overwhelmed activation, but are not beneficial in chronic infection as they suppress anti-HIV responses. Current assays used to evaluate vaccine-induced specific responses are limited as they do not take into account antigen-specific Tregs. However, new assays, such as the OX40 assay, which allow for the simultaneous detection of a full range of Th-responses including antigen-specific Tregs responses, can overcome these issues. In this review article we will revise the role of Tregs in vaccination and review the recent work performed in the field, including the available tools to monitor them, from novel assays to humanized mouse models.http://www.mdpi.com/2076-393X/4/3/30memory cellTregsHIVvaccineDC-based vaccineOX40CD25CD39hu-mice |
spellingShingle | Vedran Brezar Véronique Godot Liang Cheng Lishan Su Yves Lévy Nabila Seddiki T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials Vaccines memory cell Tregs HIV vaccine DC-based vaccine OX40 CD25 CD39 hu-mice |
title | T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials |
title_full | T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials |
title_fullStr | T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials |
title_full_unstemmed | T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials |
title_short | T-Regulatory Cells and Vaccination “Pay Attention and Do Not Neglect Them”: Lessons from HIV and Cancer Vaccine Trials |
title_sort | t regulatory cells and vaccination pay attention and do not neglect them lessons from hiv and cancer vaccine trials |
topic | memory cell Tregs HIV vaccine DC-based vaccine OX40 CD25 CD39 hu-mice |
url | http://www.mdpi.com/2076-393X/4/3/30 |
work_keys_str_mv | AT vedranbrezar tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials AT veroniquegodot tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials AT liangcheng tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials AT lishansu tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials AT yveslevy tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials AT nabilaseddiki tregulatorycellsandvaccinationpayattentionanddonotneglectthemlessonsfromhivandcancervaccinetrials |